| Title |
Handling Uncertainty in Cost-Effectiveness Models
|
|---|---|
| Published in |
PharmacoEconomics, September 2012
|
| DOI | 10.2165/00019053-200017050-00006 |
| Pubmed ID | |
| Authors |
Andrew H. Briggs |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 25% |
| New Zealand | 1 | 25% |
| United Kingdom | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 50% |
| Science communicators (journalists, bloggers, editors) | 1 | 25% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 380 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 11 | 3% |
| United States | 9 | 2% |
| Canada | 6 | 2% |
| Netherlands | 2 | <1% |
| France | 2 | <1% |
| Brazil | 2 | <1% |
| Chile | 1 | <1% |
| Ireland | 1 | <1% |
| Bangladesh | 1 | <1% |
| Other | 4 | 1% |
| Unknown | 341 | 90% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 78 | 21% |
| Student > Master | 77 | 20% |
| Student > Ph. D. Student | 60 | 16% |
| Other | 29 | 8% |
| Student > Postgraduate | 19 | 5% |
| Other | 63 | 17% |
| Unknown | 54 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 127 | 33% |
| Economics, Econometrics and Finance | 51 | 13% |
| Social Sciences | 24 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 4% |
| Business, Management and Accounting | 12 | 3% |
| Other | 75 | 20% |
| Unknown | 77 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2018.
All research outputs
#2,996,682
of 25,374,647 outputs
Outputs from PharmacoEconomics
#276
of 1,992 outputs
Outputs of similar age
#20,719
of 189,238 outputs
Outputs of similar age from PharmacoEconomics
#45
of 548 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,238 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 548 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.